EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

David Groheux, Loïc Ferrer iD, Jennifer Vargas, Antoine Martineau, Adrien Borgel, Luis Teixeira, Philippe Menu, Philippe Bertheau, Olivier Gallinato, Thierry Colin, Jacqueline Lehmann-Che iD

Cancers · 07.04.2025 · 17 (7) · 1249

DOI: 10.3390/cancers17071249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 07.04.2025. Verfasst von David Groheux und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, AP-HP, Saint-Louis Hospital, F-75010 Paris, France. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National du Cancer, French national cancer institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Triple-negative breast cancer (TNBC) is a biologically and clinically heterogeneous disease, associated with poorer outcomes when compared with other subtypes of breast cancer. Neoadjuvant chemotherapy (NAC) is often given before surgery, and achieving a pathological complete response (pCR) has been associated with patient outcomes. There is thus strong clinical interest in the ability to accurately predict pCR status using baseline data. Materials and Methods: A cohort of 57 TNBC patients who underwent FDG-PET/CT before NAC was analyzed to develop a machine learning (ML) algorithm predictive of pCR. A total of 241 predictors were collected for each patient: 11 clinical features, 11 histopathological features, 13 genomic features, and 206 PET features, including 195 radiomic features. The optimization criterion was the area under the ROC curve (AUC). Event-free survival (EFS) was estimated using the Kaplan–Meier method.

Results

The best ML algorithm reached an AUC of 0.82. The features with the highest weight in the algorithm were a mix of PET (including radiomics), histopathological, genomic, and clinical features, highlighting the importance of truly multimodal analysis. Patients with predicted pCR tended to have a longer EFS than patients with predicted non-pCR, even though this difference was not significant, probably due to the small sample size and few events observed (p = 0.09).

Conclusions

This study suggests that ML applied to baseline multimodal data can help predict pCR status after NAC for TNBC patients and may identify correlations with long-term outcomes. Patients predicted as non-pCR may benefit from concomitant treatment with immunotherapy or dose intensification.

Schlagwörter

Stichwörter der Autor:innen

FDG-PET/CTartificial intelligencemachine learningmetabolic responseneoadjuvant chemotherapypCRprognosisradiomicstriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Nuclear Medicine, AP-HP, Saint-Louis Hospital, F-75010 Paris, France.
  • Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris, France.
  • SOPHiA GENETICS, F-33600 Pessac, France.
  • Molecular Oncology Unit, AP-HP, Saint Louis Hospital, F-75010 Paris, France.
  • Breast Diseases Unit, AP-HP, Saint Louis Hospital, F-75010 Paris, France.
  • SOPHiA GENETICS, 1180 Rolle, Switzerland.

ORCID-Profile: Loïc Ferrer, Jacqueline Lehmann-Che

Förderung

  • Institut National du Cancer
  • French national cancer institute

Zitieren

APA

Groheux, D., Ferrer, L., Vargas, J., Martineau, A., Borgel, A., Teixeira, L., Menu, P., Bertheau, P., Gallinato, O., Colin, T., & Lehmann-Che, J. (2025). FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers, 17(7), 1249. https://doi.org/10.3390/cancers17071249

Vancouver

Groheux D, Ferrer L, Vargas J, Martineau A, Borgel A, Teixeira L, et al. FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers. 2025;17(7):1249. doi:10.3390/cancers17071249

BibTeX
@article{Groheux2025,
  author = {Groheux, David and Ferrer, Loïc and Vargas, Jennifer and Martineau, Antoine and Borgel, Adrien and Teixeira, Luis and Menu, Philippe and Bertheau, Philippe and Gallinato, Olivier and Colin, Thierry and Lehmann-Che, Jacqueline},
  title = {FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {1249},
  doi = {10.3390/cancers17071249}
}
Kostenlos starten →